Format

Send to

Choose Destination
Br J Haematol. 2019 Mar;184(5):853-855. doi: 10.1111/bjh.15175. Epub 2018 Mar 12.

Activated prothrombin complex concentrate (FEIBA® ) in acquired haemophilia A: a large multicentre Italian study - the FAIR Registry.

Author information

1
Haemophilia Centre, University Hospital of Padua, Padova, Italy.
2
Cellular Biotechnology and Haematology Department, Umberto I University Hospital, Roma, Italy.
3
Haemophilia Centre, S. Matteo Hospital, Pavia, Italy.
4
Centre of Haemorrhagic and Thrombotic Diseases, University of Palermo, Palermo, Italy.
5
Haemophilia and Thrombosis Centre, S. Giovanni Bosco Hospital, Napoli, Italy.
6
Centre of Coagulation Diseases, Hospital of Macerata, Macerata, Italy.
7
Haematology and Transfusion Medicine Department, Luigi Sacco Hospital, Milano, Italy.
8
Center of Coagulation Diseases, SS Annunziata Hospital, Sassari, Italy.
9
Haematology Department, VE Ferrarotto and S. Bambino University Hospital, Catania, Italy.
10
Transfusion Medicine and Immune-haematology Department, Giovanni XXIII Hospital, Bergamo, Italy.
11
Medicine Department, Humanitas Clinical Institute, Rozzano (Milano), Italy.
12
Centre of Haemorrhagic and Thrombotic Diseases, Pugliese-Ciaccio Hospital, Catanzaro, Italy.

KEYWORDS:

bleeding disorders; coagulation factors; factor VIII; haemophilia

PMID:
29528100
DOI:
10.1111/bjh.15175

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center